NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for temozolomide


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Antigenics Reports Third Quarter 2009 Financial Results
2009 NOV 9 ... in combination with the standard of care - radiation therapy plus Temodar® (temozolomide) - for newly diagnosed glioma patients. The investigator-sponsored study will evaluate ...
Subject: Antigenics Inc.
Price: $3.00
*
Ascenta Therapeutics Announces Presentation of Results From a Dose-Ranging Study of AT-101 With Standard Therapy in Patients With Glioblastoma Multiforme
2009 NOV 9 ... glioblastoma multiforme who received either AT-101 administered concurrently with temozolomide and radiation therapy (Arm 1) or AT-101 as a component of...
Subject: Glioblastoma
Price: $3.00
*
Data Presented on Oncophage(R) Cancer Vaccine in Recurrent Glioma at SNO 2009
2009 NOV 9 ... Phase 2 study is underway evaluating Oncophage in combination with Temodar® (temozolomide) in newly diagnosed glioma patients. About Oncophage Antigenics has treated nearly 800 ...
Subject: Antigenics
Price: $3.00
*
ImmunoCellular Therapeutics Presents Data from Phase I Trial of ICT-107 Demonstrating Significant Increase in Tumor-Free Progression in Patients with Brain Cancer
2009 NOV 9 ... disease-who received ICT-107 in addition to standard treatment with radiation and temozolomide, a chemotherapy product that was until recently the only approved drug for GBM. ...
Subject: ImmunoCellular Therapeutics, Ltd.
Price: $3.00
*
New brain cancer in children research from University of Florence, Department of Pediatric Hematology-Oncology discussed
2009 OCT 19 ... research published in the journal Oncology Reports, "Insufficient response to oral temozolomide (TMZ) in children with brain tumor may depend on the repair-action of inducible ...
Subject: Brain Cancer
Price: $3.00
*
New data from M. Ali et al illuminate research in DNA research
2009 NOV 16 ... underlying in vivo chemosensitization, which could widen its clinical application. Temozolomide response was analyzed in vitro and in vivo. Vessel dynamics were monitored using ...
Subject: DNA Research
Price: $3.00
*
New findings from University of California, Medical Department in the area of glioma published
2009 NOV 2 ... "Temozolomide is considered the standard of care and drug of choice for the treatment of initially ...
Subject: Glioma
Price: $3.00
*
New findings reported from Baylor College of Medicine, College of Medicine describe advances in leukemia
2009 OCT 19 ... polymerase (PARP) inhibitor ABT-888 potentiates the antitumor activity of temozolomide (TMZ). TMZ resistance results from increased O-6-methylguanine-DNA methyltransferase ...
Subject: Leukemia
Price: $3.00
*
New research on enzyme research from W.P. Roos and co-authors summarized
2009 NOV 16 ... "Temozolomide and fotemustine, representing methylating and chloroethylating agents, respectively, are ...
Subject: Enzyme Research
Price: $3.00
*
NovoCure, Ltd., Announces the Closing of a Financing Round Including New Investors Pfizer Inc, Johnson & Johnson Development Corporation and Index Ventures
2009 OCT 12 ... efficacy of the novel Novo-TTF device in combination with standard-of-care chemotherapy (temozolomide) compared to standard-of-care chemotherapy alone in patients with newly-diagnosed GBM is ...
Subject: Cancer
Price: $3.00
*
Recent findings in carcinoma described by A.P. Lozier and colleagues
2009 NOV 16 ... grounds. Postoperatively, the patient was treated by local radiotherapy and temozolomide. A magnetic resonance imaging scan 44 months after surgery showed no evidence of ...
Subject: Carcinoma
Price: $3.00
*
Reports on glioblastoma findings from Mayo Clinic provide new insights
2009 OCT 12 ... According to a study from the United States, "Concurrent temozolomide (TMZ) and radiation therapy (RT) followed by adjuvant TMZ is standard treatment for ...
Subject: Glioblastoma
Price: $3.00
*
Research from M. Wyss and co-researchers yields new findings on glioma
2009 NOV 2 ... We investigated the time course of tumor metabolism in low-grade gliomas (LGG) during temozolomide chemotherapy, and compared metabolic responses as measured with positron emission ...
Subject: Glioma
Price: $3.00
*
Research from University of Regensburg reveals new findings on glioblastoma
2009 NOV 9 ... "Although Temozolomide is effective against glioblastoma, the prognosis remains dismal and new regimens with ...
Subject: Glioblastoma
Price: $3.00
*
Researchers from University of Heidelberg report on findings in angiogenesis
2009 OCT 12 ... 2. It was therefore decided to administer continuous low-dose chemotherapy with temozolomide and celecoxib for antiangiogenic treatment in the four patients that were in good ...
Subject: Angiogenesis
Price: $3.00
*
Scientists at Wake Forest University publish research in clinical trial research
2009 NOV 2 ... respectively. The studies seek to evaluate the efficacy of radiotherapy and either temozolomide or a combination of procarbazine, vincristine, and lomustine in high-risk LGG patients. ...
Subject: Clinical Trial Research
Price: $3.00
*
Studies from B.J. George and colleagues reveal new findings on aplastic anemia
2009 NOV 2 ... with glioblastoma multiforme (GBM) developed aplastic anemia following treatment with temozolomide. Following her diagnosis of GBM, the patient received standard treatment with surgery, ...
Subject: Aplastic Anemia
Price: $3.00
*
Study findings from G.B. Roldan et al broaden understanding of life sciences
2009 NOV 16 ... "Chemoradiotherapy followed by monthly temozolomide (TMZ) is the standard of care for patients with glioblastoma multiforme (GBM). reports ...
Subject: Life Sciences
Price: $3.00
*
Study findings from University of Florida, McKnight Brain Institute broaden understanding of life sciences
2009 NOV 2 ... Despite a lack of definitive evidence, this strategy has commonly been extrapolated to Temozolomide. Chemo-sensitivity of AO/mixed-AOs provides the rationale for the chemotherapy-only ...
Subject: Life Sciences
Price: $3.00
*
Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference
2009 NOV 16 ... study of XL765 (SAR245409), a novel PI3K/TORC1/TORC2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with malignant glioma will be presented on Tuesday, November 17, ...
Subject: Exelixis, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login